Aging and age-related diseases of the ocular lens and vitreous body

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 14, 2013, Pages

  Petrash, J Mark ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cataract; PCO; Presbyopia; Vitreous humor

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AGING; AMINO ACID SEQUENCE; ARTICLE; CAPSULOTOMY; CELL PROLIFERATION; GERIATRIC DISORDER; HUMAN; LENS; LENS CAPSULE; NONHUMAN; OCULAR FIBROSIS; PHACOEMULSIFICATION; PLIABILITY; PRESBYOPIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; SENILE CATARACT; VISUAL IMPAIRMENT; VITREOUS BODY;

EID: 84890399697     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12940     Document Type: Article

References (28)

1. Salm M, Belsky D, Sloan FA. Trends in cost of major eye diseases to Medicare, 1991 to 2000. Am J Ophthalmol. 2006; 142:976-982.
2. Rao GN, Khanna R, Payal A. The global burden of cataract. Curr Opin Ophthalmol. 2011;22:4-9.
3. Cvekl A, Piatigorsky J. Lens development and crystallin gene expression: many roles for Pax-6. Bioessays. 1996;18:621-630.
4. Bassnett S. Lens organelle degradation. Exp Eye Res. 2002;74:1-6.
5. Nagaraj RH, Linetsky M, Stitt AW. The pathogenic role of Maillard reaction in the aging eye. Amino Acids. 2012;42: 1205-1220.
6. Moreau KL, King JA. Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends Mol Med. 2012;18:273-282.
7. Benedek GB. Cataract as a protein condensation disease: the Proctor Lecture. Invest Ophthalmol Vis Sci. 1997;38:1911-1921.
8. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A. 1992;89:10449-10453.
9. Bhattacharyya J, Padmanabha Udupa EG, Wang J, Sharma KK. Mini-alphaB-crystallin: a functional element of alphaB-crystallin with chaperone-like activity. Biochemistry. 2006;45:3069-3076.
10. Datiles MB III, Ansari RR, Suh KI, et al. clinical detection of precataractous lens protein changes using dynamic light scattering. Arch Ophthalmol. 2008;126:1687-1693.
11. McFall-Ngai MJ, Ding LL, Takemoto LJ, Horwitz J. Spatial and temporal mapping of the age-related changes in human lens crystallins. Exp Eye Res. 1985;41:745-758.
12. Sreekumar PG, Chothe P, Sharma KK, et al. Antiapoptotic properties of alpha-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells. Invest Ophthalmol Vis Sci. 2013;54:2787-2798.
13. Nahomi RB, Wang B, Raghavan CT, et al. Chaperone peptides of alpha-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts. J Biol Chem. 2013;288:13022-13035.
14. Mueller NH, Ammar DA, Petrash JM. Cell penetration peptides for enhanced entry of alphaB-crystallin into lens cells. Invest Ophthalmol Vis Sci. 2013;54:2-8.
15. Wormstone IM. Posterior capsule opacification: a cell biological perspective. Exp Eye Res. 2002;74:337-347.
16. Chong CC, Stump RJ, Lovicu FJ, McAvoy JW. TGFbeta promotes Wnt expression during cataract development. Exp Eye Res. 2009;88:307-313.
17. Saika S, Yamanaka O, Sumioka T, et al. Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res. 2008;27:177-196.
18. Wormstone IM, Wang L, Liu CS. Posterior capsule opacification. Exp Eye Res. 2009;88:257-269.
19. Yadav UC, Ighani-Hosseinabad F, van Kuijk FJ, Srivastava SK, Ramana KV. Prevention of posterior capsular opacification through aldose reductase inhibition. Invest Ophthalmol Vis Sci. 2009;50:752-759.
20. Heys KR, Cram SL, Truscott RJ. Massive increase in the stiffness of the human lens nucleus with age: the basis for presbyopia? Mol Vis. 2004;10:956-963.
21. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res. 2005;80:709-725.
22. Nishi Y, Mireskandari K, Khaw P, Findl O. Lens refilling to restore accommodation. J Cataract Refract Surg. 2009;35: 374-382.
23. Hsuan JD, Brown NA, Bron AJ, Patel CK, Rosen PH. Posterior subcapsular and nuclear cataract after vitrectomy. J Cataract Refract Surg. 2001;27:437-444.
24. Harocopos GJ, Shui YB, McKinnon M, Holekamp NM, Gordon MO, Beebe DC. Importance of vitreous liquefaction in agerelated cataract. Invest Ophthalmol Vis Sci. 2004;45:77-85.
25. Holekamp NM, Shui YB, Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol. 2006;141:1027-1032.
26. Holekamp NM, Bai F, Shui YB, Almony A, Beebe DC. Ischemic diabetic retinopathy may protect against nuclear sclerotic cataract. Am J Ophthalmol. 2010;150:543-550. e1.
27. Beebe DC, Holekamp NM, Siegfried C, Shui YB. Vitreoretinal influences on lens function and cataract. Philos Trans R Soc Lond B Biol Sci. 2011;366:1293-1300.
28. National Advisory Eye Council. Vision Research: A National Plan 1983-1987. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1983.